Alexion Pharmaceuticals, Inc. · 1 day ago
System Admin Intern
Alexion Pharmaceuticals, Inc. is seeking Junior and Master's students for a 12-week internship role. The position involves managing the implementation of the ServiceNow BMC module, organizing project plans, and supporting team site content development.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Manage the ongoing implementation of the ServiceNow BMC module. Develop orientation plans, support workshops and user focus group action plans
Organize and communicate project plans, setup up workshop and support lead
Work with new technology to master functionality and gather information to create requirements for new functionality
Support the develop of the team site content and update of site
Qualification
Required
Junior and Master's students studying Cybersecurity, Computer Science, Business, Operations, Statistics, or a related discipline
Candidates must have an expected graduation date after August 2026
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week
Preferred
Experience with Tableua, Excel, PowerBI, and ServiceNow
Prior experience with a cloud-based (AWS / Azure / GSP) platform
Prior project development experience with large project exposure
Prior hands-on background with technology infrastructure and applications (e.g. technology stacks) in resiliency programming is a plus
Personal develop working directly with senior leadership and Technical Engineers
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase